MoneyWorks4Me

Cipla signs agreements to acquire 21.85% stake in GoApptiv

10 Jun 2020 Evaluate

Cipla has signed agreements to acquire shares representing 21.85% stake in GoApptiv on a fully diluted basis. Through an equity investment, the company will strengthen its partnership with GoApptiv so as to enable widening reach of its key brands in the Tier 3+ towns through GoApptiv’s solutions for end-to-end brand marketing and channel engagement.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..